Effects, safety, and plasma levels of topiroxostat and its metabolites in patients receiving hemodialysis
Crossref DOI link: https://doi.org/10.1186/s41100-016-0068-5
Published Online: 2016-10-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oyama, Satoko
Hirose, Chihiro
Hori, Kenichiro
Sugano, Katsuhiro
Zhang, Jie
Tamura, Miyuki
Tomita, Kimio